These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9704469)

  • 1. Antenatal genotyping of the blood groups of the fetus.
    Avent ND
    Vox Sang; 1998; 74 Suppl 2():365-74. PubMed ID: 9704469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi.
    Fisk NM; Bennett P; Warwick RM; Letsky EA; Welch R; Vaughan JI; Moore G
    Am J Obstet Gynecol; 1994 Jul; 171(1):50-4. PubMed ID: 8030733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive antenatal RHD typing.
    Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
    Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rh haemolytic disease of the newborn and Rh genotyping by RFLP--and allele-specific--PCR.
    Le Van Kim C; Colin Y; Brossard Y; Cartron JP
    Transfus Clin Biol; 1995; 2(4):317-24. PubMed ID: 8542030
    [No Abstract]   [Full Text] [Related]  

  • 7. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
    Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S; Tijane M; Benchemsi N
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage.
    Shields JA
    Br J Biomed Sci; 1999; 56(1):49-55. PubMed ID: 10492915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
    Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
    Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction.
    Legler TJ; Lynen R; Maas JH; Pindur G; Kulenkampff D; Suren A; Osmers R; Köhler M
    Transfus Apher Sci; 2002 Dec; 27(3):217-23. PubMed ID: 12509216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal determination of fetal RhD type by DNA amplification.
    Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
    N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
    Orzińska A; Guz K; Brojer E
    Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal DNA in maternal plasma: application to non-invasive blood group genotyping of the fetus.
    Lo YM
    Transfus Clin Biol; 2001 Jun; 8(3):306-10. PubMed ID: 11499983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.